APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autoimmune Disease Diagnostics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Autoimmune Disease Diagnostics Industry Growth and Trends Forecast to 2032

20 December 2025124 pages

Choose your research edition.

Industry ResearchAutoimmune Disease Diagnostics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmune Disease Diagnostics Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Autoimmune Disease Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmune Disease Diagnostics Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmune Disease Diagnostics Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

According to APO Research, the global Autoimmune Disease Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Autoimmune Disease Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Autoimmune Disease Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autoimmune Disease Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Autoimmune Disease Diagnostics market include Abbott Laboratories, Autoimmune Technologies, Avant Diagnostics, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, ERBA Diagnostics, Euro Diagnostica and EUROIMMUN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Autoimmune Disease Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Autoimmune Disease Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Autoimmune Disease Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Autoimmune Disease Diagnostics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Autoimmune Disease Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Autoimmune Disease Diagnostics Market by Company

Abbott Laboratories

Autoimmune Technologies

Avant Diagnostics

Beckman Coulter

Bio-Rad Laboratories

DiaSorin

ERBA Diagnostics

Euro Diagnostica

EUROIMMUN

Exagen Diagnostics

Gold Standard Diagnostics

HOB Diagnostics

HUMAN Diagnostics

Immco Diagnostics

ImmunArray

Inova Diagnostics

Myriad Genetics

Omega Diagnostics

ORGENTEC Diagnostika

Phadia

Protagen

Roche Diagnostics

Siemens Healthcare

Autoimmune Disease Diagnostics Segment by Type

Analyzers

Assay Kits

Autoimmune Disease Diagnostics Segment by Application

Hospitals

Research Laboratories

Autoimmune Disease Diagnostics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmune Disease Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmune Disease Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmune Disease Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Autoimmune Disease Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Autoimmune Disease Diagnostics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Autoimmune Disease Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Autoimmune Disease Diagnostics Market Share by Region (2021-2026) Table 4. Global Autoimmune Disease Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Autoimmune Disease Diagnostics Market Share by Region (2027-2032) Table 6. Global Autoimmune Disease Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Autoimmune Disease Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Autoimmune Disease Diagnostics Market Size Share by Type (2021-2026) Table 9. Global Autoimmune Disease Diagnostics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Autoimmune Disease Diagnostics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Autoimmune Disease Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Autoimmune Disease Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Autoimmune Disease Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Autoimmune Disease Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Autoimmune Disease Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Autoimmune Disease Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Autoimmune Disease Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Autoimmune Disease Diagnostics Market Size Share by Application (2021-2026) Table 24. Global Autoimmune Disease Diagnostics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Autoimmune Disease Diagnostics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Autoimmune Disease Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Autoimmune Disease Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Autoimmune Disease Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Autoimmune Disease Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Autoimmune Disease Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Autoimmune Disease Diagnostics Industry Trends Table 37. Autoimmune Disease Diagnostics Industry Drivers Table 38. Autoimmune Disease Diagnostics Industry Opportunities and Challenges Table 39. Autoimmune Disease Diagnostics Industry Restraints Table 40. Global Autoimmune Disease Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Autoimmune Disease Diagnostics Revenue Market Share by Company (2021-2026) Table 42. Global Autoimmune Disease Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Autoimmune Disease Diagnostics Key Company Headquarters & Area Served Table 44. Global Autoimmune Disease Diagnostics Company, Product Type & Application Table 45. Global Autoimmune Disease Diagnostics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Autoimmune Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Laboratories Company Information Table 49. Abbott Laboratories Business Overview Table 50. Abbott Laboratories Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 52. Abbott Laboratories Recent Development Table 53. Autoimmune Technologies Company Information Table 54. Autoimmune Technologies Business Overview Table 55. Autoimmune Technologies Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio Table 57. Autoimmune Technologies Recent Development Table 58. Avant Diagnostics Company Information Table 59. Avant Diagnostics Business Overview Table 60. Avant Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 62. Avant Diagnostics Recent Development Table 63. Beckman Coulter Company Information Table 64. Beckman Coulter Business Overview Table 65. Beckman Coulter Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio Table 67. Beckman Coulter Recent Development Table 68. Bio-Rad Laboratories Company Information Table 69. Bio-Rad Laboratories Business Overview Table 70. Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 72. Bio-Rad Laboratories Recent Development Table 73. DiaSorin Company Information Table 74. DiaSorin Business Overview Table 75. DiaSorin Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. DiaSorin Autoimmune Disease Diagnostics Product Portfolio Table 77. DiaSorin Recent Development Table 78. ERBA Diagnostics Company Information Table 79. ERBA Diagnostics Business Overview Table 80. ERBA Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 82. ERBA Diagnostics Recent Development Table 83. Euro Diagnostica Company Information Table 84. Euro Diagnostica Business Overview Table 85. Euro Diagnostica Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio Table 87. Euro Diagnostica Recent Development Table 88. EUROIMMUN Company Information Table 89. EUROIMMUN Business Overview Table 90. EUROIMMUN Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio Table 92. EUROIMMUN Recent Development Table 93. Exagen Diagnostics Company Information Table 94. Exagen Diagnostics Business Overview Table 95. Exagen Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 97. Exagen Diagnostics Recent Development Table 98. Gold Standard Diagnostics Company Information Table 99. Gold Standard Diagnostics Business Overview Table 100. Gold Standard Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 102. Gold Standard Diagnostics Recent Development Table 103. HOB Diagnostics Company Information Table 104. HOB Diagnostics Business Overview Table 105. HOB Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 107. HOB Diagnostics Recent Development Table 108. HUMAN Diagnostics Company Information Table 109. HUMAN Diagnostics Business Overview Table 110. HUMAN Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 112. HUMAN Diagnostics Recent Development Table 113. Immco Diagnostics Company Information Table 114. Immco Diagnostics Business Overview Table 115. Immco Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 117. Immco Diagnostics Recent Development Table 118. ImmunArray Company Information Table 119. ImmunArray Business Overview Table 120. ImmunArray Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. ImmunArray Autoimmune Disease Diagnostics Product Portfolio Table 122. ImmunArray Recent Development Table 123. Inova Diagnostics Company Information Table 124. Inova Diagnostics Business Overview Table 125. Inova Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 127. Inova Diagnostics Recent Development Table 128. Myriad Genetics Company Information Table 129. Myriad Genetics Business Overview Table 130. Myriad Genetics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio Table 132. Myriad Genetics Recent Development Table 133. Omega Diagnostics Company Information Table 134. Omega Diagnostics Business Overview Table 135. Omega Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 137. Omega Diagnostics Recent Development Table 138. ORGENTEC Diagnostika Company Information Table 139. ORGENTEC Diagnostika Business Overview Table 140. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio Table 142. ORGENTEC Diagnostika Recent Development Table 143. Phadia Company Information Table 144. Phadia Business Overview Table 145. Phadia Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Phadia Autoimmune Disease Diagnostics Product Portfolio Table 147. Phadia Recent Development Table 148. Protagen Company Information Table 149. Protagen Business Overview Table 150. Protagen Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Protagen Autoimmune Disease Diagnostics Product Portfolio Table 152. Protagen Recent Development Table 153. Roche Diagnostics Company Information Table 154. Roche Diagnostics Business Overview Table 155. Roche Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 157. Roche Diagnostics Recent Development Table 158. Siemens Healthcare Company Information Table 159. Siemens Healthcare Business Overview Table 160. Siemens Healthcare Autoimmune Disease Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio Table 162. Siemens Healthcare Recent Development Table 163. North America Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Autoimmune Disease Diagnostics Market Share by Country (2021-2026) Table 166. North America Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Autoimmune Disease Diagnostics Market Share Forecast by Country (2027-2032) Table 168. Europe Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Autoimmune Disease Diagnostics Market Share by Country (2021-2026) Table 171. Europe Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Autoimmune Disease Diagnostics Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Country (2021-2026) Table 176. Asia-Pacific Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Autoimmune Disease Diagnostics Market Share Forecast by Country (2027-2032) Table 178. Latin America Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Autoimmune Disease Diagnostics Market Share by Country (2021-2026) Table 181. Latin America Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Autoimmune Disease Diagnostics Market Share Forecast by Country (2027-2032) Table 183. Middle East & Africa Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Country (2021-2026) Table 186. Middle East & Africa Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East & Africa Autoimmune Disease Diagnostics Market Share Forecast by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Autoimmune Disease Diagnostics Product Image Figure 3. Global Autoimmune Disease Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Autoimmune Disease Diagnostics Market Size (2021-2032) & (US$ Million) Figure 5. Global Autoimmune Disease Diagnostics Market Share by Region: 2025 VS 2032 Figure 6. Global Autoimmune Disease Diagnostics Market Share by Region (2021-2032) Figure 7. North America Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Analyzers Image Figure 13. Global Analyzers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Assay Kits Image Figure 15. Global Assay Kits Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Autoimmune Disease Diagnostics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Autoimmune Disease Diagnostics Market Share by Type 2025 VS 2032 Figure 18. North America Autoimmune Disease Diagnostics Market Size Share by Type (2021-2032) Figure 19. Europe Autoimmune Disease Diagnostics Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Autoimmune Disease Diagnostics Market Size Share by Type (2021-2032) Figure 21. Latin America Autoimmune Disease Diagnostics Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Autoimmune Disease Diagnostics Market Size Share by Type (2021-2032) Figure 23. Hospitals Image Figure 24. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Research Laboratories Image Figure 26. Global Research Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Autoimmune Disease Diagnostics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Autoimmune Disease Diagnostics Market Share by Application 2025 VS 2032 Figure 29. North America Autoimmune Disease Diagnostics Market Size Share by Application (2021-2032) Figure 30. Europe Autoimmune Disease Diagnostics Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Autoimmune Disease Diagnostics Market Size Share by Application (2021-2032) Figure 32. Latin America Autoimmune Disease Diagnostics Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Autoimmune Disease Diagnostics Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Autoimmune Disease Diagnostics Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Autoimmune Disease Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Autoimmune Disease Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 39. Europe Autoimmune Disease Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Autoimmune Disease Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 42. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 45. Latin America Autoimmune Disease Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Autoimmune Disease Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 48. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Analyzers
  • Assay Kits
Applications
  • Hospitals
  • Research Laboratories
Companies covered
  • Abbott Laboratories
  • Autoimmune Technologies
  • Avant Diagnostics
  • Beckman Coulter
  • Bio-Rad Laboratories
  • DiaSorin
  • ERBA Diagnostics
  • Euro Diagnostica
  • EUROIMMUN
  • Exagen Diagnostics
  • Gold Standard Diagnostics
  • HOB Diagnostics
  • HUMAN Diagnostics
  • Immco Diagnostics
  • ImmunArray
  • Inova Diagnostics
  • Myriad Genetics
  • Omega Diagnostics
  • ORGENTEC Diagnostika
  • Phadia
  • Protagen
  • Roche Diagnostics
  • Siemens Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Autoimmune Disease Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Autoimmune Disease Diagnostics Market Size by Region (2021-2032)
  5. 1.4.1 Global Autoimmune Disease Diagnostics Market Size by Region (2021-2026)
  6. 1.4.2 Global Autoimmune Disease Diagnostics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Autoimmune Disease Diagnostics Market Size (2021-2032)
  8. 1.5.1 North America Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Autoimmune Disease Diagnostics Market Size Growth Rate (2021-2032)
2 Autoimmune Disease Diagnostics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Analyzers
  3. 2.1.2 Assay Kits
  4. 2.2 Global Autoimmune Disease Diagnostics Market Size by Type
  5. 2.2.1 Global Autoimmune Disease Diagnostics Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Autoimmune Disease Diagnostics Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Autoimmune Disease Diagnostics Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Autoimmune Disease Diagnostics Market Size by Regions
  9. 2.3.1 North America Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Autoimmune Disease Diagnostics Market Size Breakdown by Type (2021-2026)
3 Autoimmune Disease Diagnostics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Research Laboratories
  4. 3.2 Global Autoimmune Disease Diagnostics Market Size by Application
  5. 3.2.1 Global Autoimmune Disease Diagnostics Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Autoimmune Disease Diagnostics Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Autoimmune Disease Diagnostics Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Autoimmune Disease Diagnostics Market Size by Regions
  9. 3.3.1 North America Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Autoimmune Disease Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Autoimmune Disease Diagnostics Industry Trends
  2. 4.2 Autoimmune Disease Diagnostics Industry Drivers
  3. 4.3 Autoimmune Disease Diagnostics Industry Opportunities and Challenges
  4. 4.4 Autoimmune Disease Diagnostics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Autoimmune Disease Diagnostics Revenue (2021-2026)
  2. 5.2 Global Autoimmune Disease Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Autoimmune Disease Diagnostics Key Company Headquarters & Area Served
  4. 5.4 Global Autoimmune Disease Diagnostics Company, Product Type & Application
  5. 5.5 Global Autoimmune Disease Diagnostics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Autoimmune Disease Diagnostics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Autoimmune Disease Diagnostics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Autoimmune Disease Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Autoimmune Technologies
  8. 6.2.1 Autoimmune Technologies Company Information
  9. 6.2.2 Autoimmune Technologies Business Overview
  10. 6.2.3 Autoimmune Technologies Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio
  12. 6.2.5 Autoimmune Technologies Recent Developments
  13. 6.3 Avant Diagnostics
  14. 6.3.1 Avant Diagnostics Company Information
  15. 6.3.2 Avant Diagnostics Business Overview
  16. 6.3.3 Avant Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  18. 6.3.5 Avant Diagnostics Recent Developments
  19. 6.4 Beckman Coulter
  20. 6.4.1 Beckman Coulter Company Information
  21. 6.4.2 Beckman Coulter Business Overview
  22. 6.4.3 Beckman Coulter Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio
  24. 6.4.5 Beckman Coulter Recent Developments
  25. 6.5 Bio-Rad Laboratories
  26. 6.5.1 Bio-Rad Laboratories Company Information
  27. 6.5.2 Bio-Rad Laboratories Business Overview
  28. 6.5.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio
  30. 6.5.5 Bio-Rad Laboratories Recent Developments
  31. 6.6 DiaSorin
  32. 6.6.1 DiaSorin Company Information
  33. 6.6.2 DiaSorin Business Overview
  34. 6.6.3 DiaSorin Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 DiaSorin Autoimmune Disease Diagnostics Product Portfolio
  36. 6.6.5 DiaSorin Recent Developments
  37. 6.7 ERBA Diagnostics
  38. 6.7.1 ERBA Diagnostics Company Information
  39. 6.7.2 ERBA Diagnostics Business Overview
  40. 6.7.3 ERBA Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  42. 6.7.5 ERBA Diagnostics Recent Developments
  43. 6.8 Euro Diagnostica
  44. 6.8.1 Euro Diagnostica Company Information
  45. 6.8.2 Euro Diagnostica Business Overview
  46. 6.8.3 Euro Diagnostica Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio
  48. 6.8.5 Euro Diagnostica Recent Developments
  49. 6.9 EUROIMMUN
  50. 6.9.1 EUROIMMUN Company Information
  51. 6.9.2 EUROIMMUN Business Overview
  52. 6.9.3 EUROIMMUN Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio
  54. 6.9.5 EUROIMMUN Recent Developments
  55. 6.10 Exagen Diagnostics
  56. 6.10.1 Exagen Diagnostics Company Information
  57. 6.10.2 Exagen Diagnostics Business Overview
  58. 6.10.3 Exagen Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  60. 6.10.5 Exagen Diagnostics Recent Developments
  61. 6.11 Gold Standard Diagnostics
  62. 6.11.1 Gold Standard Diagnostics Company Information
  63. 6.11.2 Gold Standard Diagnostics Business Overview
  64. 6.11.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  66. 6.11.5 Gold Standard Diagnostics Recent Developments
  67. 6.12 HOB Diagnostics
  68. 6.12.1 HOB Diagnostics Company Information
  69. 6.12.2 HOB Diagnostics Business Overview
  70. 6.12.3 HOB Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  72. 6.12.5 HOB Diagnostics Recent Developments
  73. 6.13 HUMAN Diagnostics
  74. 6.13.1 HUMAN Diagnostics Company Information
  75. 6.13.2 HUMAN Diagnostics Business Overview
  76. 6.13.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  78. 6.13.5 HUMAN Diagnostics Recent Developments
  79. 6.14 Immco Diagnostics
  80. 6.14.1 Immco Diagnostics Company Information
  81. 6.14.2 Immco Diagnostics Business Overview
  82. 6.14.3 Immco Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  84. 6.14.5 Immco Diagnostics Recent Developments
  85. 6.15 ImmunArray
  86. 6.15.1 ImmunArray Company Information
  87. 6.15.2 ImmunArray Business Overview
  88. 6.15.3 ImmunArray Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 ImmunArray Autoimmune Disease Diagnostics Product Portfolio
  90. 6.15.5 ImmunArray Recent Developments
  91. 6.16 Inova Diagnostics
  92. 6.16.1 Inova Diagnostics Company Information
  93. 6.16.2 Inova Diagnostics Business Overview
  94. 6.16.3 Inova Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  96. 6.16.5 Inova Diagnostics Recent Developments
  97. 6.17 Myriad Genetics
  98. 6.17.1 Myriad Genetics Company Information
  99. 6.17.2 Myriad Genetics Business Overview
  100. 6.17.3 Myriad Genetics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio
  102. 6.17.5 Myriad Genetics Recent Developments
  103. 6.18 Omega Diagnostics
  104. 6.18.1 Omega Diagnostics Company Information
  105. 6.18.2 Omega Diagnostics Business Overview
  106. 6.18.3 Omega Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  108. 6.18.5 Omega Diagnostics Recent Developments
  109. 6.19 ORGENTEC Diagnostika
  110. 6.19.1 ORGENTEC Diagnostika Company Information
  111. 6.19.2 ORGENTEC Diagnostika Business Overview
  112. 6.19.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio
  114. 6.19.5 ORGENTEC Diagnostika Recent Developments
  115. 6.20 Phadia
  116. 6.20.1 Phadia Company Information
  117. 6.20.2 Phadia Business Overview
  118. 6.20.3 Phadia Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Phadia Autoimmune Disease Diagnostics Product Portfolio
  120. 6.20.5 Phadia Recent Developments
  121. 6.21 Protagen
  122. 6.21.1 Protagen Company Information
  123. 6.21.2 Protagen Business Overview
  124. 6.21.3 Protagen Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Protagen Autoimmune Disease Diagnostics Product Portfolio
  126. 6.21.5 Protagen Recent Developments
  127. 6.22 Roche Diagnostics
  128. 6.22.1 Roche Diagnostics Company Information
  129. 6.22.2 Roche Diagnostics Business Overview
  130. 6.22.3 Roche Diagnostics Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  132. 6.22.5 Roche Diagnostics Recent Developments
  133. 6.23 Siemens Healthcare
  134. 6.23.1 Siemens Healthcare Company Information
  135. 6.23.2 Siemens Healthcare Business Overview
  136. 6.23.3 Siemens Healthcare Autoimmune Disease Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio
  138. 6.23.5 Siemens Healthcare Recent Developments
7 North America
  1. 7.1 North America Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  3. 7.3 North America Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  3. 8.3 Europe Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  3. 10.3 South America Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst